KR890004709A - 항원충제로서의 아지트로마이신 및 이의 유도체 - Google Patents

항원충제로서의 아지트로마이신 및 이의 유도체 Download PDF

Info

Publication number
KR890004709A
KR890004709A KR1019880011575A KR880011575A KR890004709A KR 890004709 A KR890004709 A KR 890004709A KR 1019880011575 A KR1019880011575 A KR 1019880011575A KR 880011575 A KR880011575 A KR 880011575A KR 890004709 A KR890004709 A KR 890004709A
Authority
KR
South Korea
Prior art keywords
azithromycin
pharmaceutical composition
composition according
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
KR1019880011575A
Other languages
English (en)
Other versions
KR930011996B1 (ko
Inventor
사무엘 레밍톤 잭
Original Assignee
윌리암 데이비스 훈
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 윌리암 데이비스 훈, 화이자 인코포레이티드 filed Critical 윌리암 데이비스 훈
Publication of KR890004709A publication Critical patent/KR890004709A/ko
Application granted granted Critical
Publication of KR930011996B1 publication Critical patent/KR930011996B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

항원충제로서의 아지트로마이신 및 이의 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 아지트로마이신, 4''-에피-아지트로마이신, 4''-아미노-4''-데옥시-아지트로마이신 또는 4''-에피-4''-아미노-4''-데옥시-아지트로마이신, 또는 이의 약제학적으로 허용되는 염의 항원충 유효량을 약제학적으로 허용되는 담체(들)와의 배합물 형태로 함유함을 특징으로 하는, 포유류에서 원충류 감염을 치료 또는 예방하는데 사용되는 약제학적 조성물.
  2. 제1항에 있어서, 아지트로마이신 또는 이의 약제학적으로 허용되는 염을 함유함을 특징으로 하는 약제학적 조성물.
  3. 제1항에 있어서, 아지트로마이신 이수화물을 함유함을 특징으로 하는 약제학적 조성물.
  4. 제1항에 있어서, 4''-에피-아지트로마이신 또는 이의 약제학적으로 허용되는 염을 함유함을 특징으로 하는 약제학적 조성물.
  5. 제1항에 있어서, 4''-아미노-4''-데옥시-아지트로마이신 또는 이의 약제학적으로 허용되는 염을 함유함을 특징으로 하는 약제학적 조성물.
  6. 제1항에 있어서, 톡소플라즈마 곤디(Toxoplasma gondii) 균주에 기인된 원충류 감염의 치료 또는 예방을 위한 약제학적 조성물.
  7. 제6항에 있어서, 아지트로마이신 또는 이의 약제학적으로 허용되는 염을 함유함을 특징으로 하는 약제학적 조성물.
  8. 제7항에 있어서, 아지트로마이신 이수화물을 함유함을 특징으로 하는 약제학적 조성물.
  9. 제6항에 있어서, 4''-에피-아지트로마이신을 함유함을 특징으로 하는 약제학적 조성물.
  10. 제6항에 있어서, 4''-아미노-4''-데옥시-아지트로마이신 함유함을 특징으로 하는 약제학적 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880011575A 1987-09-10 1988-09-08 항원충제로서의 아지트로마이신 및 이의 유도체의 용도 KR930011996B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
USPCT/US/87/02317 1987-09-10
PCT/US1987/002317 WO1989002271A1 (en) 1987-09-10 1987-09-10 Azithromycin and derivatives as antiprotozoal agents
US87/02317 1987-09-10

Publications (2)

Publication Number Publication Date
KR890004709A true KR890004709A (ko) 1989-05-09
KR930011996B1 KR930011996B1 (ko) 1993-12-23

Family

ID=22202554

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880011575A KR930011996B1 (ko) 1987-09-10 1988-09-08 항원충제로서의 아지트로마이신 및 이의 유도체의 용도

Country Status (18)

Country Link
US (1) US4963531A (ko)
EP (1) EP0307128B1 (ko)
JP (1) JPH0667847B2 (ko)
KR (1) KR930011996B1 (ko)
AT (1) ATE74508T1 (ko)
AU (1) AU596029B2 (ko)
CA (1) CA1334574C (ko)
DE (1) DE3869880D1 (ko)
DK (1) DK175544B1 (ko)
HU (1) HUT47553A (ko)
IE (1) IE61507B1 (ko)
IL (1) IL87698A (ko)
MY (1) MY103388A (ko)
NZ (1) NZ226112A (ko)
PH (1) PH26229A (ko)
PT (1) PT88448B (ko)
WO (1) WO1989002271A1 (ko)
ZA (1) ZA886727B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1295719C (zh) * 2003-12-30 2007-01-17 郑玉庆 远程智能型变压器

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2066324C1 (ru) 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
TW271400B (ko) * 1992-07-30 1996-03-01 Pfizer
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
ES2095772T3 (es) * 1993-05-05 1997-02-16 Palo Alto Medical Found Utilizacion de derivados de rifamicina para producir un medicamento destinado al tratamiento de la toxoplasmosis.
KR970702725A (ko) * 1994-04-26 1997-06-10 노부히로 나리따 비소세포 폐암 치료용 의약 조성물(Medicinal Composition as a Remedy for Nonsmall Cell Lung Cancer)
AU744318B2 (en) * 1994-04-29 2002-02-21 Pfizer Inc. Method of administering azithromycin
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CZ292360B6 (cs) * 1994-05-06 2003-09-17 Pfizer Inc. Dávkovací forma s řízeným uvolňováním obsahující azithromycin a způsob její výroby
US20030212123A1 (en) * 1997-05-05 2003-11-13 Pfizer Inc. COX-2 selective carprofen for treating pain and inflammation in dogs
US6407074B1 (en) * 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
ATE267835T1 (de) * 1997-10-16 2004-06-15 Pliva Pharm & Chem Works Neue 9a-azalide
EP1152765B1 (en) * 1998-11-30 2004-10-13 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
IT1313610B1 (it) 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
US6608033B1 (en) * 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
US6586576B2 (en) 2000-01-04 2003-07-01 Teva Pharmaceutical Industries Ltd Preparation method of azithromycin hydrates
WO2002007736A1 (en) * 2000-07-24 2002-01-31 Cadila Pharmaceuticals Limited The process for manufacturing of clear liquid pharmaceutical composition of azithromycin
DE60026718T2 (de) 2000-07-25 2006-11-16 Laboratorio Silanes, S.A. De C.V. Einstufiges verfahren zur herstellung von 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle(11.2.11)hexadeca-1(2)-en-8-ona undeine neue form von 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
AU2001214115A1 (en) * 2000-08-01 2002-02-13 Habil F. Khorakiwala Process for the preparation of anhydrous azithromycin
EP1313749B1 (en) * 2000-08-23 2005-10-12 Wockhardt Limited Process for preparation of anhydrous azithromycin
SK287814B6 (sk) * 2000-11-27 2011-11-04 Sandoz Ag Azithromycin in the form of a monohydrate, a process for its preparation and pharmaceutical compositions comprising same
KR100491183B1 (ko) 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
US6861413B2 (en) * 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EA007618B1 (ru) * 2001-05-22 2006-12-29 Пфайзер Продактс Инк. Кристаллический полуторогидрат азитромицина, содержащая его фармацевтическая композиция и способ лечения на его основе
SI1390377T1 (sl) 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
CZ2004232A3 (cs) * 2001-08-21 2005-10-12 Pfizer Products Inc. Jednorázová dávka azithromycinu
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
US6764997B2 (en) * 2001-10-18 2004-07-20 Teva Pharmaceutical Industries Ltd. Stabilized azithromycin compositions
CN1668282A (zh) * 2001-12-21 2005-09-14 辉瑞产品公司 可直接压制的阿齐霉素配方
CN1606433A (zh) * 2001-12-21 2005-04-13 辉瑞产品公司 阿齐霉素湿法制粒法
WO2003063838A1 (en) * 2002-02-01 2003-08-07 Pfizer Products Inc. Dry granulated formulations of azithromycin
ES2220229B1 (es) * 2003-05-29 2005-10-16 Quimica Sintetica, S.A. Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
CN1889931A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾－冻凝方法
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
ES2308274T3 (es) 2003-12-04 2008-12-01 Pfizer Products Inc. Procedimiento para fabricar multiparticulados farmaceuticos.
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
BRPI0417348A (pt) 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
WO2006115494A1 (en) * 2005-04-26 2006-11-02 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions
CN100427499C (zh) * 2005-12-20 2008-10-22 山东诚创医药技术开发有限公司 一种阿奇霉素的可溶性盐及其制备方法
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
AU8280087A (en) * 1987-09-10 1989-04-17 Pfizer Inc. Azithromycin and derivatives as antiprotozoal agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1295719C (zh) * 2003-12-30 2007-01-17 郑玉庆 远程智能型变压器

Also Published As

Publication number Publication date
PT88448A (pt) 1989-07-31
JPH0283326A (ja) 1990-03-23
PT88448B (pt) 1992-10-30
HUT47553A (en) 1989-03-28
EP0307128A3 (en) 1990-07-04
DE3869880D1 (de) 1992-05-14
ZA886727B (en) 1990-04-25
EP0307128B1 (en) 1992-04-08
DK175544B1 (da) 2004-11-29
IE61507B1 (en) 1994-11-02
PH26229A (en) 1992-04-01
NZ226112A (en) 1997-03-24
MY103388A (en) 1993-06-30
JPH0667847B2 (ja) 1994-08-31
KR930011996B1 (ko) 1993-12-23
ATE74508T1 (de) 1992-04-15
CA1334574C (en) 1995-02-28
EP0307128A2 (en) 1989-03-15
IE882762L (en) 1989-03-10
IL87698A (en) 1992-12-01
AU2206188A (en) 1989-05-11
WO1989002271A1 (en) 1989-03-23
IL87698A0 (en) 1989-02-28
AU596029B2 (en) 1990-04-12
US4963531A (en) 1990-10-16
DK502888D0 (da) 1988-09-09
DK502888A (da) 1989-03-13

Similar Documents

Publication Publication Date Title
KR890004709A (ko) 항원충제로서의 아지트로마이신 및 이의 유도체
LU88712I2 (fr) TAXOTERE-Décotaxel
KR890003720A (ko) 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제
DE69025336D1 (de) Antihypertensive Zubereitungen und deren Verwendung
DE3783683D1 (de) Hautpenetration verbessernde zusammensetzungen.
ATE166572T1 (de) Ranitidin enthaltende kautabletten
DE69122805D1 (de) Antivirusmittel
NL960024I1 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus gesmette patiënten.
ATE96822T1 (de) Benzotriazolgruppenhaltiges diorganopolysiloxan.
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
KR890006639A (ko) 벤조티아진 디옥사이드 유도체
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
DE68929321D1 (de) Therapeutische Anwendungen von 2',5'-Oligoadenylat-Derivaten
DE3772403D1 (de) Zitronensaeurederivate als emulgatoren fuer die emulsationspolymerisation.
FR2389597A1 (ko)
ES2058196T3 (es) Derivados de azacromano.
SE8007569L (sv) Fosningsmedel jemte sett att dermed framstella stabila losningar lempliga for parenteral administration
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
KR840004431A (ko) 히단토인 치료제
DE3686266D1 (de) Neue 5-fluoruridin-verbindungen und deren herstellung.
DK0459176T3 (da) Oligophosphater med antiviral virkning
ATE124950T1 (de) Nucleosid-analoge.
DE3572670D1 (de) 13-alpha-alkyl-17-beta-(3-acyloxy-propyl)-gonane
KR920019354A (ko) 9-아미노-1,2,3,4- 테트라하이드로아크리딘-1-올 및 관련 화합물의 aids치료용 용도
FR2379545A1 (ko)

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E601 Decision to refuse application
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20071011

Year of fee payment: 15

EXPY Expiration of term